Get real-time access to our massive inventory of high quality, ethically procured, and comprehensively characterized biospecimens, so you can build smarter study cohorts for preclinical, translational, and clinical research studies faster.
Accelerate your research with our extensive human blood inventory from whole blood to double-spun plasma and immune cell isolates.
Discovery offers a wide range of human diseased blood specimens, collected from our expansive global clinical site network, and normal blood-derived products from the Discovery Donor Clinic.
Gain an understanding of disease pathogenesis and identify novel therapeutic targets with our full-spectrum, non-blood human biospecimens, from cerebrospinal fluid to respiratory swabs.
The Discovery Partners® network allows for large-scale, prospective collections of high-quality non-blood biofluids and each sample comes with comprehensive patient data
AllCells®, a Discovery Life Sciences brand, is an industry leader in the procurement and customization of human-derived hematological tissues and services.
AllCells provides high quality GMP and RUO products and services that help global life science researchers and bio-manufacturing organizations access high quality cell and gene therapy starting material to speed development of immunotherapies, vaccines, and cell and gene therapies.
At Discovery, we commit to acquire the leading technologies, employ the most dedicated and brightest minds from every culture, walk of life, and region of the world. We come together to accelerate and advance science. We accomplish this by partnering with researchers in industry, academia, and governments, enabling them to complete their important work faster by providing them the highest quality products and services, while assuring that we will strictly adhere to every ethical, legal, and regulatory standard.
We will never waiver from these commitments…because patients are waiting®.
Nearly 200 clinical sources. In dozens of countries across the world. Access to hundreds of thousands of patients. These clinical partners comprise of nearly 200 sites, all with experience in recruiting patients with the ideal attributes for the most complex research protocol objectives.
Discovery’s sample collection includes annotated companion data and, in many cases, follow-up clinical information over time. Following specimen collection, our team will aliquot, label, store, package, distribute and perform custom laboratory services to the specifications requested by our clients.
Discovery Life Sciences is dedicated to sustaining an inclusive workplace where individuals from diverse backgrounds and perspectives are welcomed and valued.
We are expanding our workforce and its diversity to enhance our ability to meet the needs of researchers around the world with unique, innovative solutions. We require all Discovery Life Science locations around the world to adhere to a common culture of decency, fairness, equality, and respect for all humans. Discovery Life Sciences does not discriminate in employment opportunities or practices on the basis of race, color, religion, gender, national origin, age, disability, ancestry, gender identity or expression, marital status, veteran status, medical conditions, family care status, sexual orientation, or any other basis.
If you care about the work you do and the amazing people that work aside you, then consider Discovery Life Sciences.
Discovery Life Sciences is the company of Biospecimen™ and Biomarker Specialists™, combining the world’s largest commercial biospecimen inventory and procurement network with globally recognized service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions. We are a leading provider of highly characterized human cellular starting materials and expert multi-omic analytical services to advance cell and gene therapy research, development, and manufacturing programs.
Stay current with Discovery! Touch base to follow our newest Press Releases, industry events, sponsored conferences, virtual webinars, and upcoming presentations by our thought leaders. Follow our recent news or events calendar below!
SITC 2025
CLONE FROM HERE
Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies
World ADC 2025
Biomarkers & Precision Medicine US 2025
ASHG 2025
No Record Found
